iCAC Device vs AVIEW Lung Nodule CAD
AI Verdict
Choose iCAC Device if…
Choose Bunkerhill Health's iCAC Device if your primary goal is the opportunistic identification and quantification of coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans. This tool is ideal for integrating into existing radiology workflows to leverage incidental findings for early cardiovascular disease detection without requiring dedicated cardiac CT protocols. It provides precise Agatston unit quantification to aid in cardiovascular risk stratification.
View iCAC Device →Choose AVIEW Lung Nodule CAD if…
Choose Coreline Soft Co.'s AVIEW Lung Nodule CAD if your institution requires a comprehensive AI solution for multi-faceted thoracic CT analysis, encompassing lung cancer screening, COPD assessment, and cardiovascular risk. This tool is particularly well-suited for lung screening programs or radiology departments needing simultaneous detection and analysis of pulmonary nodules, quantitative emphysema analysis, and coronary artery calcification scoring from a single chest CT scan, streamlining reporting with features like Lung-RADS classification and nodule volume doubling time.
View AVIEW Lung Nodule CAD →When choosing between Bunkerhill Health’s iCAC Device and Coreline Soft Co.’s AVIEW Lung Nodule CAD, physicians should consider their primary focus and workflow. The iCAC Device is specifically designed for the opportunistic detection and quantification of coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans. It excels at providing precise Agatston unit estimates and visual segmentations of CAC, making it ideal for practices primarily concerned with early cardiovascular disease detection from existing imaging data.
In contrast, AVIEW Lung Nodule CAD offers a broader suite of AI-powered tools, encompassing not only coronary artery calcification scoring but also comprehensive pulmonary nodule detection, classification, and quantification, alongside emphysema analysis. The key practical difference lies in their scope: iCAC is a specialized tool for CAC, while AVIEW Lung Nodule CAD is a multi-faceted solution for lung health screening that includes CAC as one component. Therefore, a radiologist or cardiologist whose main objective is to leverage incidental CAC findings from various chest CTs for cardiovascular risk assessment would find the iCAC Device more tailored to their needs.
Conversely, a pulmonologist or a radiology department focused on comprehensive lung cancer screening, follow-up, and COPD assessment, who also desires opportunistic CAC scoring, would benefit more from the integrated capabilities of AVIEW Lung Nodule CAD. The choice ultimately depends on whether the physician requires a dedicated CAC analysis tool or a more expansive AI platform for general thoracic imaging interpretation.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | iCAC Device | AVIEW Lung Nodule CAD |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AVIEW Lung Nodule CADTool B (AVIEW Lung Nodule CAD) offers automatic report generation based on Lung-RADS classification, which streamlines the reporting process for radiologists. Additionally, its flexible deployment options (cloud, hybrid, local) provide greater adaptability to various IT infrastructures, potentially enhancing ease of integration and use.
Clinical Value
AVIEW Lung Nodule CADTool B (AVIEW Lung Nodule CAD) provides a more comprehensive clinical assessment by simultaneously analyzing lung nodules, emphysema, and coronary artery calcification (the 'Big 3') from a single CT scan. This broader scope offers greater potential for opportunistic disease detection and holistic patient evaluation compared to Tool A's sole focus on CAC.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing, making it impossible to compare their cost-effectiveness or value proposition. Neither provides publicly disclosed pricing models or detailed information on potential cost savings.
Enterprise Readiness
AVIEW Lung Nodule CADTool B (AVIEW Lung Nodule CAD) demonstrates stronger enterprise readiness with explicit HIPAA compliance and a wider array of deployment options, including cloud, hybrid, local hardware, and virtualized solutions. This flexibility allows for better integration into diverse hospital IT environments and addresses key security and data privacy concerns.
Innovation
AVIEW Lung Nodule CADTool B (AVIEW Lung Nodule CAD) exhibits greater innovation through its 'Big 3' approach, integrating lung nodule detection, emphysema analysis, and CAC scoring into a single, comprehensive AI solution. This multi-faceted analysis from a single scan represents a more advanced and holistic screening paradigm.
Support & Docs
TieNeither the provided structured facts nor web searches yielded specific, publicly available information regarding dedicated support portals, detailed user manuals, or extensive documentation for either product. Therefore, it is not possible to differentiate between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | iCAC Device | AVIEW Lung Nodule CAD |
|---|---|---|
| Tool Name | iCAC Device | AVIEW Lung Nodule CAD |
| Company | Bunkerhill Health | Coreline Soft Co. |
| Primary Detection Focus | Detects and quantifies coronary artery calcium (CAC) | Assists in detecting and analyzing pulmonary nodules, offers comprehensive screening for lung cancer, COPD, and coronary artery calcification |
| Key Quantification/Analysis Metrics | Estimates presence and quantity of CAC, delivers exact and four-category quantitative estimates of CAC burden in Agatston units | AI-based pulmonary nodule detection (3-20 mm), nodule classification, 3D nodule size and volume quantification, automatic report generation based on Lung-RADS, nodule matching and VDT calculation, quantitative emphysema analysis, Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass scores) |
| Analyzed Scan Modality/Type | Routine, non-contrast, non-gated chest CT scans | Chest CT scans |
| Integration Capabilities | Integrates with PACS or DICOM router, integrates with EHRs via the Carebricks platform | Not specified |
| Supported Medical Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring iCAC Device and AVIEW Lung Nodule CAD.